Evidence map›Paper›PMID 31353224›Full record

ArticleStem cell reports2019

Elevated Exogenous Pyruvate Potentiates Mesodermal Differentiation through Metabolic Modulation and AMPK/mTOR Pathway in Human Embryonic Stem Cells.

Chengcheng Song, Faxiang Xu, Zhili Ren, Yumeng Zhang, Ya Meng, Yiqi Yang, Shreyas Lingadahalli, Edwin Cheung, Gang Li, Weiwei Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic regulation in the senescence process of stem cells.Stem cells translational medicine · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. International journal of molecular sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Chengcheng SongCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China.
Faxiang XuCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China.
Zhili RenCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China.
Yumeng ZhangCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China.
Ya MengCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China; Center of Interventional Radiology, Zhuhai Precision Medical Center, Zhuhai People's Hospital, Jinan University, Zhuhai, Guangdong 519000, China.
Yiqi YangCancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
Shreyas LingadahalliCancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
Edwin CheungCancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
Gang LiCancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
Weiwei LiuCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China; Bioimaging and Stem Cell Core Facility, Faculty of Health Sciences, University of Macau, Macau, China.
Jianbo WanState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Yang ZhaoThe MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.
Guokai ChenCentre of Reproduction, Development and Aging, Faculty of Health Sciences, University of Macau, Macau, China; Bioimaging and Stem Cell Core Facility, Faculty of Health Sciences, University of Macau, Macau, China. Electronic address: guokaichen@umac.mo.
University of Macau · MOCenter for Life Sciences · CNZhuhai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyruvate is a key metabolite in glycolysis and the tricarboxylic acid (TCA) cycle. Exogenous pyruvate modulates metabolism, provides cellular protection, and is essential for the maintenance of human preimplantation embryos and human embryonic stem cells (hESCs). However, little is known about how pyruvate contributes to cell-fate determination during epiblast stage. In this study, we used hESCs as a model to demonstrate that elevated exogenous pyruvate shifts metabolic balance toward oxidative phosphorylation in both maintenance and differentiation conditions. During differentiation, pyruvate potentiates mesoderm and endoderm lineage specification. Pyruvate production and its mitochondrial metabolism are required in BMP4-induced mesoderm differentiation. However, the TCA-cycle metabolites do not have the same effect as pyruvate on differentiation. Further study shows that pyruvate increases AMP/ATP ratio, activates AMPK, and modulates the mTOR pathway to enhance mesoderm differentiation. This study reveals that exogenous pyruvate not only controls metabolism but also modulates signaling pathways in hESC differentiation.

Indexed as

AMP-Activated Protein KinasesBone Morphogenetic Protein 4Cell DifferentiationCell LineageCitric Acid CycleEndodermHomeodomain ProteinsHuman Embryonic Stem CellsHumansMesodermMitochondriaOxidative PhosphorylationPyruvic AcidSignal TransductionT-Box Domain ProteinsTOR Serine-Threonine KinasesAMP-Activated Protein KinasesBone Morphogenetic Protein 4Homeodomain ProteinsMIXL1 protein, humanMTOR protein, humanPyruvic AcidT-Box Domain ProteinsTOR Serine-Threonine KinasesAMPKBMP4differentiationglycolysishESCsmesodermmetabolismpyruvateTCA cycleWNT

Identifiers

PMID31353224
PMCPMC6700476
OpenAlexW2962873011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.